Description: Attend this webcast to learn more on how to navigate managing ESG principles in the new normal of a post-COVID world. Enhance your ESG insights in a post-pandemic landscape.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: How do Professionalism and the Actuarial Standards of Practice apply as the way we work and tools we use continue to change? Business is conducted via social media and messaging and Generative AI allows for additional scenarios, analysis and oversight. Join us for an interactive session to go deeper into these topics including case studies, polls and a panel discussion.

Description: Learn how modernization of data, models, and technology are influencing workflows. This webcast will address how workflows are changing in response to new regulatory requirements and the impacts the changes have on modeling and end-to-end future state operating models. Industry leading actuaries will discuss: How team collaboration can increase quality and speed of reporting to internal and external stakeholders How to strengthen controls and compliance frameworks across finance and actuarial departments How to modernize actuarial input/output for strategic analysis and insights How to attract and retain top talent by improving opportunities for actuaries There will also be dedicated time to ask questions of those who have made the transition.

Description: This report presents Phase 2 of the 2024 IDEC Study, analyzing individual disability income (IDI) claim recovery and mortality rates from 2006-2014. It expands Phase 1's scope—previously limited to 90-day elimination and To Age 65-70 benefit periods—to include additional elimination and benefit periods, examining variations by diagnosis, occupation class, claim year, and gender.

Description: This report is a study. It discusses the objectives, scope, methodology, and limitations of the study, focusing on how diagnosis affects disability income claim recovery and mortality rates.

Description: This report focuses on the Fixed Indexed Annuity (FIA) contract owner behavior study conducted by the SOA Research Institute and LIMRA for the years 2021-2022. It includes detailed analyses on withdrawals, surrender rates, contract values, distribution channels, and more.

Description: This is a request for surrender experience data for fixed-rate deferred annuities for the years 2023-2024 from the SOA Research Institute and LIMRA, outlining goals for updating a prior study and offering detailed outputs through a paid subscription to Experience Studies Pro.

Description: How do Professionalism and the Actuarial Standards of Practice apply as the way we work and tools we use continue to change? Business is conducted via social media and messaging and Generative AI allows for additional scenarios, analysis and oversight. Join us for an interactive session to go deeper into these topics including case studies, polls and a panel discussion.

Description: Dive into an overview of potential customer value propositions, trends in consumer acceptance and adoption, solving the data portability issue, potential impacts of emerging partner ships with OEMs and more within the auto insurance industry during our latest webcast. Experience interactive dialogue that will allow another dimension of thinking as industry experts provide insights and expertise. Throughout this webcast, you can expect developments in the personal lines automotive telematics-based insurance landscape that will develop a further understanding of the present and future of this industry.